Leveraging Mobile Health Technology to Optimize Early Stimulant Medication Treatment: A Feasibility Pilot

NCT01990222 | Completed

• 2 other identifiers: UL1TR000124IRB#12-001879
• Study Type: observational
• Target: 26
• Locations: 1 country
• Sites: 3

Brief Summary

The goal of this study is to develop and test a mobile web application to optimize early stimulant medication treatment for children receiving care for Attention/Deficit Hyperactivity Disorder (ADHD) in a publicly-funded mental health clinic.

Conditions

Attention Deficit Disorder With Hyperactivity

Keywords

ADHD

Outcome Measures

Primary Outcomes (1)

• Stimulant medication adherence

  parent-reported stimulant medication adherence

  medication follow-up visit 1- visit 3, approx 8 weeks, depending on scheduling of the 3 med visits, usually 1 every 2 weeks

Secondary Outcomes (2)

• Parent-provider communication

  Once every two weeks for each participant, over approx 8 weeks, depending on scheduling of the 3 med visits, usually 1 every 2 weeks

• Clinic follow-up visit attendance

  medication follow-up visit 1-visit 3, approx 8 weeks, depending on scheduling of the 3 med visits, usually 1 every 2 weeks

Other Outcomes (1)

• Parent-centered medication management

  between medication follow-up visit 1- visit 3, over approx 8 weeks, depending on scheduling of the 3 med visits, usually 1 every 2 weeks

Eligibility Criteria

• Age: 5 Years - 12 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17)
• Sampling Method: Non-Probability Sample

Study Population

Parents taking their children to Augustus Hawkins Mental Health Center for treatment of ADHD who were prescribed stimulant medication for the first time. The attending physicians will work at the clinic.

You may qualify if:

• parent's and child's primary language is English or Spanish
• child is between 5-11 years
• child received a clinical diagnosis of ADHD
• child is receiving stimulant medication for the first time
• child does not take any other medication on a regular basis (like every day)

You may not qualify if:

• any chronic medical condition that requires on-going medication management
• prescription of combined psychotropic medication
• moderate-severe developmental delays, mental retardation or autism

Sponsors & Collaborators

• University of California, Los Angeles: lead

Study Sites (3)

Augustus Hawkins Mental Health Center

Los Angeles, California, 90059, United States

Location

UCLA Children's Health Center

Los Angeles, California, 90095, United States

Location

Child and Family Guidance Center

Northridge, California, 91325, United States

Location

MeSH Terms

Conditions

Attention Deficit Disorder with Hyperactivity

Condition Hierarchy (Ancestors)

Attention Deficit and Disruptive Behavior Disorders; Neurodevelopmental Disorders; Mental Disorders

Study Officials

• Bonnie Zima, MD, MPH

  University of California, Los Angeles

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associate Director of the Jane and Terry Semel Institute's Health Services Research Center and Professor-in-Residence in the UCLA Department of Psychiatry and Behavioral Sciences at the David Geffen School of Medicine

Study Record Dates

• First Submitted: July 1, 2013
• First Posted: November 21, 2013
• Study Start: January 1, 2014
• Primary Completion: October 1, 2018
• Study Completion: October 1, 2018
• Last Updated: February 17, 2020

Record last verified: 2020-02

Locations

US (3)